Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
“No Evidence” Exists That Ephedra Ban Shifted Burden Of Proof, Agency Says
Nov 14 2005
•
By
Melina A. Vissat
More from Archive
More from Pink Sheet